Adelene Q. Perkins, President & Chief Executive Officer at INFINITY PHARMACEUTICALS, INC. (INFI), bought 25,000 shares at $6.10 ($153K) on 2010-12-16, disclosed to the SEC on 2010-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 809 | $5K | 3.2% |
| 2 | $6.10 | 14,191 | $87K | 56.7% |
| 3 | $6.12 | 10,000 | $61K | 40.1% |
| Total | $6.10 avg | 25,000 | $153K | 100% |
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |